Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

The Westin Boston Waterfront

Aug 15, 2016 7:30 AM - Aug 18, 2016 5:00 PM

425 Summer Street, Boston, MA 02210

Regulatory Affairs: The IND, NDA, and Postmarketing

Session 26: Review of Prescription Drug/Biologics Advertising and Promotional Labeling

Session Chair(s)

Drusilla  Scott, PhD, RAC

Drusilla Scott, PhD, RAC

Vice President, Regulatory Affairs

Sobi, Inc., United States

Carol H. Danielson, DrPH, MS, RAC

Carol H. Danielson, DrPH, MS, RAC

President

Regulatory Advantage, LLC, United States

  • Definitions
  • Statutory Basis for Promotional Regulations
  • Required Elements for Advertisements and Promotional Labeling
  • Reminder Advertisements/Labeling
  • Preapproval Promotional Activities
  • Other Topics
  • FDA Enforcement Actions
  • Launch of Promotional Pieces
  • Postmarketing Submission of Advertising
  • Summary of Principles for Advertising and Promotion

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.